• How Condensate Coronas Enable RNA Transfer

  2026-11-06

  A rare subset of internalized nanoparticles can acquire cell-derived biomolecular condensates, leave the cell, and deliver intact proteins and RNAs to recipient-cell compartments. The evidence supports a mechanism involving condensate formation, endosomal fluidization, and selective intracellular release, while leaving important questions about molecular recognition, frequency, and generalizability unresolved.

• How Condensate Coronas Enable RNA Transfer

  2026-11-05

  A recent study describes rare nanoparticle–cell hybrids in which a cell-derived condensate corona appears to organize the transfer of intact proteins and RNAs between cells. The strongest evidence links endosomal condensate detachment, non-endolysosomal access and reporter activity, while the physiological prevalence and generality of the mechanism remain uncertain.

• How Condensate Coronas Enable RNA Transfer

  2026-11-05

  A mechanistic analysis of how rare nanoparticle–condensate complexes acquire, stabilize and transfer intact proteins and RNAs between cells, with emphasis on endosomal release, functional readouts and the limits of current evidence.

• What Rare Nanoparticle Complexes Reveal About RNA Transfer

  2026-11-04

  A recent study describes a rare class of cell-derived condensate–nanoparticle complexes that can move proteins and RNA between cells. Its findings support a mechanistic model involving condensate acquisition, endosomal separation and intracellular access, while leaving major questions about frequency, causality and generalizability unresolved.

• How Condensate Coronas Transfer RNA Between Cells

  2026-11-04

  A Nature Materials study identifies rare nanoparticle–condensate hybrids that carry intact proteins and RNAs between cells. Its evidence links corona composition, endosomal separation and reporter-based functional transfer, while leaving important questions about particle heterogeneity, biological generality and in vivo relevance.

• When Condensate Coronas Redirect Nanoparticles

  2026-11-03

  Can a nanoparticle acquire a cell-derived biomolecular layer that changes its intracellular fate? The study presents evidence that a rare hybrid particle state can separate from endosomal compartments and redistribute proteins and RNA-associated material inside cells, while differing molecularly from extracellular vesicles.

• Context Changes What p53 mRNA Results Mean

  2026-11-03

  Results involving p53-encoding mRNA cannot be interpreted apart from the carrier, tumor model, comparator, immune setting and readout. A 2025 review supports a biologically plausible but formulation-specific interpretation of lipid nanoparticle delivery, while reported p53 findings remain indirect, mainly preclinical and insufficient to validate any particular material.

• Condensate Coronas and Cellular Cargo Transfer

  2026-11-02

  A mechanistic cell-biology study describes how a rare nanoparticle subpopulation acquires a cell-derived condensate corona, is re-exported, and can separate from its core after endosomal uptake. Comparative molecular analyses distinguish these hybrid complexes from extracellular vesicles and support a recognition-dependent route for intracellular redistribution of proteins and RNA.

• Rare-Event Nanoparticle Cargo Transfer

  2026-11-02

  A published study describes a rare class of nanoparticle–condensate complexes that can carry intact proteins and RNA between cells. Its comparisons support a distinctive intracellular trafficking mechanism, while leaving unresolved how often the event occurs, how broadly it applies, and whether reporter activity represents native biological function.

• How Condensate Coronas Transfer Biomolecules

  2026-11-01

  A literature-focused analysis of how rare nanoparticle–cell condensate complexes acquire, protect and transfer proteins and RNAs, and what the evidence does—and does not—establish about their mechanism and broader applicability.

• How Condensate Coronas Transfer Biomolecular Cargo

  2026-10-31

  A literature-focused analysis of how synthetic nanoparticles can acquire cell-derived biomolecular condensate coronas, become re-exported, and deliver intact proteins and RNAs to recipient cells. The study distinguishes these lipid-poor complexes from extracellular vesicles and identifies endosomal separation, condensate fluidization, and interface recognition as key mechanistic features, while leaving important questions about frequency, cargo completeness, and generalizability unresolved.

• How Condensate Coronas Re-route Nanoparticle Cargo

  2026-10-30

  A comparative cell-biology study examines how synthetic nanoparticles acquire cell-derived biomolecular condensate coronas and how those coronas influence intracellular trafficking. The findings support a recognition-dependent route for transferring protein and RNA cargo, while remaining limited to cultured-cell models and rare heterogeneous events.

• How Condensate Coronas Move Biomolecules Between Cells

  2026-10-30

  A literature-focused analysis of how a rare nanoparticle-associated condensate pathway may transfer intact proteins and RNAs between cells, what measurements support the proposed mechanism, and where the evidence remains limited.

• What Does a DAT IC50 Actually Show?

  2026-10-29

  A reported IC50 of 118 nM supports a narrow interpretation of Benztropine mesylate as a dopamine transporter inhibitor in an assay-specific context. It does not by itself establish effects in cells, neural circuits, behavior, disease models, or treatment.

• What Nanoparticle Condensate Coronas Actually Show

  2026-10-29

  Published evidence describes a rare nanoparticle–cell hybrid that can preserve and transfer proteins and RNA, while leaving major questions about particle heterogeneity, cargo functionality, and generalizability unresolved.

8174 records 1/545 page Next 12345 下5页 Last page